Jane Street Group, LLC Macrogenics Inc Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $417,300 - $772,005	139,100 New	139,100 $457,000
Q3 2021 Nov 16, 2021	SELL	$19.74 - $28.7 $138,180 - $200,900	-7,000 Reduced 36.84%	12,000 $251,000
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $258,173 - $448,938	-12,600 Reduced 39.87%	19,000 $510,000
Q1 2021 May 18, 2021	BUY	$18.99 - $33.2 $366,506 - $640,760	19,300 Added 156.91%	31,600 $1.01 Million
Q4 2020 Feb 17, 2021	BUY	$19.41 - $26.0 $238,743 - $319,800	12,300 New	12,300 $281,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.